Drug treatment of obsessive-compulsive disorder

M Kellner - Dialogues in clinical neuroscience, 2010 - Taylor & Francis
Knowledge of pharmacotherapeutic treatment options in obsessive-compulsive disorder
(OCD) has grown considerably over the past 40 years. Serotonergic antidepressants, such …

Biological approaches to treatment-resistant obsessive-compulsive disorder

WK Goodman, HE Ward, AS Kablinger… - Obsessive …, 1999 - taylorfrancis.com
University of Florida College of Medicine Obsessive-compulsive disorder (OCD) is usually
chronic, often debilitating, and more common than previously believed. Not long ago, it was …

Cognitive behavioral treatments for obsessive compulsive disorder

ME Franklin, EB Foa - A guide to treatments that work, 2002 - books.google.com
Cognitive behavioral therapy (CBT) involving exposure and ritual prevention (EX/RP) is a
wellestablished treatment for obsessive-compulsive disorder (OCD) in adults. Support for its …

Quetiapine augmentation in patients with treatment resistant obsessive–compulsive disorder: a single-blind, placebo-controlled study

M Atmaca, M Kuloglu, E Tezcan… - International clinical …, 2002 - journals.lww.com
Recently, atypical antipsychotics have been used for the management of the patients with
refractory obsessive–compulsive disorder (OCD). The aim of the present study was to …

Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder.

CJ McDougle, LC Barr, WK Goodman… - The American journal …, 1995 - europepmc.org
Objective The authors assessed the efficacy of clozapine monotherapy for adults with
treatment-resistant obsessive-compulsive disorder. Method Twelve adults with refractory …

Clozapine: a review of its pharmacological properties and therapeutic use in patients with schizophrenia who are unresponsive to or intolerant of classical …

AJ Wagstaff, HM Bryson - CNS drugs, 1995 - Springer
Synopsis Clozapine is an atypical antipsychotic agent whose mode of action is thought to
pertain to its interactions with dopamine and serotonin (5-hydroxytryptamine) …

An update on obsessive-compulsive disorder

MA Jenike - Bulletin of the Menninger Clinic, 2001 - Guilford Press
It is now recognized that obsessive-compulsive disorder (OCD) affects almost 3% of the
world's population and is a major worldwide health problem. Much has been learned in the …

Critical review of the use of second-generation antipsychotics in obsessive–compulsive and related disorders

D Kim, NL Ryba, J Kalabalik, L Westrich - Drugs in R&D, 2018 - Springer
Currently, all second-generation antipsychotics are approved for schizophrenia. Many are
also approved for bipolar disorder, with some also approved as adjunctive treatment for …

Clozapine in the treatment of obsessive-compulsive symptoms in schizophrenia patients: a case series study

I Reznik, I Yavin, R Stryjer, B Spivak… - …, 2004 - thieme-connect.com
Introduction: Obsessive-compulsive (OC) symptoms have been observed in a substantial
proportion of schizophrenic patients. There are some reports describing the appearance de …

Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study

PBF Bergqvist, J Dong, P Blier - Psychopharmacology, 1999 - Springer
Low doses of the atypical antipsychotic drug risperidone are effective in patients with
obsessive compulsive disorder (OCD) not responding to serotonin (5-HT) reuptake …